Australians don't want to be treated like guinea pigs and sheep. The madness of mRNA.

Our academic institutions and scientific leaders must be held to account for their insane deals with private industry profiteers.

The Madness of mRNA: Australia’s Descent into Technological Chaos

Australia is on the verge of an unprecedented disaster, driven by the adoption of mRNA technology—a platform whose dangers I believe are not only known but recklessly ignored. The recent unveiling of a $96 million mRNA factory in Sydney epitomises a broader madness, where profit and power triumph over public welfare, safety, and environmental integrity. At its core, I see this technology as a threat to pollute not just human health but all living matter on Earth, far surpassing the devastation wrought by microplastics.

The potential for mRNA technology to wreak havoc on the environment cannot be overstated. Unlike plastics, which primarily accumulate in physical environments, rogue mRNA and its derivatives infiltrate biological systems, altering the very essence of life. mRNA from COVID vaccines has already demonstrated the ability to shed—a process where genetic material from vaccinated individuals can transfer to others. This opens Pandora’s box for the contamination of ecosystems and the genetic manipulation of unintended targets, including plants, animals, and microorganisms. The consequences of such chaos are unimaginable: the expression of DNA in countless species could be disrupted, leading to cascading effects on biodiversity and ecological balance.

This genetic pollution dwarfs the already dire crisis of microplastics. Microplastics, while persistent and damaging, are inert. They do not replicate, nor do they have the capacity to rewrite the genetic code of organisms. In contrast, mRNA and its lipid nanoparticle carriers have the potential to transform life itself, creating a world where nature is no longer natural but a chaotic, uncontrolled experiment.

As an Australian, I pride myself on our nation’s intelligence and resilience, yet I cannot ignore the fact that we have been deceived. The use of taxpayer dollars to fund mRNA factories—while basic medical necessities like IV drip bags remain in critical shortage and vaccine damaged patients cannot afford decent nutrition—is a betrayal of public trust. It feels as though the Australian people are being treated as guinea pigs in a grand experiment, herded like sheep by a government more interested in appeasing global pharmaceutical giants than addressing the genuine needs of its citizens.

The silence of regulatory bodies like the TGA, which has allowed clinical trials to proceed with minimal oversight, underscores the depth of this betrayal. We deserve to know that our taxes are not funding public health but lining the pockets of international corporations through “public-private partnerships”—a modern form of fascism where the state and corporations merge to suppress dissent and prioritise profit over people.

Proponents of mRNA technology celebrate its “transformative” potential, claiming it enables biology to become engineering. Yet this hubris ignores the fundamental unpredictability of tampering with genetic material. While mRNA is marketed as a tool for medical miracles, its applications extend far beyond healthcare. As highlighted by many, it is poised to invade industries ranging from agriculture to cosmetics. The risks of such widespread use are compounded by the rush to capitalise on expiring patents, with little regard for long-term consequences.

The planned Moderna factory at Monash University exemplifies the deeper entanglement of public institutions with private corporate interests. Positioned as a beacon of scientific progress, more likely BS (Bad Science), this factory strikes me as little more than a confidence trick being played on well-meaning scientists. It represents not just a potential conflict of interest but also a colossal waste of taxpayer money. The billions funneled into this venture could have been better spent addressing pressing public health needs or investing in proven, safer technologies. Instead, it locks Australia into dependency on a single, experimental platform while enriching foreign pharmaceutical interests.

The money and skill being invested in mRNA technology represent a deliberate choice by the rich and powerful to prioritise patented drugs—products that, in my view, have never been proven to be both effective and safe. This prioritisation comes at the expense of exploring and advancing alternative, transformative fields such as nutrigenomics. Nutrigenomics, the study of how nutrients influence gene expression, offers a revolutionary approach to healthcare. It holds the potential to prevent and treat diseases by leveraging natural, readily available, and cost-effective solutions.

Imagine if facilities like the Moderna factory were repurposed to research the benefits of nutrigenomics. By understanding how vitamins, minerals, and other nutrients can modulate the human genome, we could embrace a healthcare model focused on prevention and holistic well-being. For example:

1. Vitamin D and Magnesium: These nutrients play critical roles in immune function, bone health, cardiovascular disorders and gene regulation. Optimising levels could help prevent a range of chronic conditions, including autoimmune diseases, hypertension and osteoporosis.

2. Omega-3 Fatty Acids: Known for their anti-inflammatory properties, omega-3s influence genes involved in cardiovascular and brain health, reducing the risk of heart disease and neurodegenerative conditions.

3. Sulforaphane from Broccoli: This compound activates protective genes that detoxify carcinogens and combat oxidative stress, offering a natural defences against cancer.

4. Trace elements and vitamin B: The reversal of pre-malignant conditions such as cervical dysplasia, bronchial dysplasia (cancer of the lung) and colon dysplasia (cancer of the bowel).

5. Vitamin A, vitamin C, Zinc and selenium: The prevention of the recurrence of cancers

This approach represents what I consider to be the proper healthcare of the future—cheap, effective, and in the best interests of everyone, animals plants and the environment. Nutrigenomics exemplifies how we can harness the wisdom of nature to improve human health without causing harm to the environment or compromising ethical standards.

The deployment of mRNA technology without fully understanding its long-term effects raises significant ethical concerns. Informed consent—a cornerstone of medical ethics—has been systematically undermined, with populations effectively treated as subjects in a large-scale genetic experiment. The lack of transparency around the risks of mRNA technology compounds this ethical failure, leaving individuals unable to make truly free and informed decisions about their health.

Australia’s embrace of mRNA technology should be analyzed within a global context. While some nations adopt similar approaches, others exercise caution, imposing stricter regulations or prioritising traditional, well-studied medical interventions. Australia’s rush into mRNA development, without adequately considering these international differences, exposes its population to unnecessary risks and alienates it from more balanced global strategies.

By relying on foreign corporations for mRNA patents and production capabilities, Australia also jeopardises its biological sovereignty. This dependence could lead to national security risks, especially as biotechnology becomes a geopolitical tool. What happens when key resources or technologies are withheld, or when foreign interests dictate the terms of Australian healthcare policies. The rush to implement mRNA technology reflects a broader trend of prioritising speed and profit over safety and due diligence. Historical parallels, such as the asbestos crisis, the mismanagement of nuclear waste, or the widespread abuse by covid vaccination serve as stark warnings. When innovation is driven by financial incentives rather than thoughtful consideration of long-term impacts, the result is often disaster.

Governments and corporations have exploited psychological mechanisms such as manipulative and induced fear and appeals to ‘progress’ to push mRNA technology onto the public. This manufactured compliance silences dissent and fosters a culture of blind trust in authority. Such strategies erode critical thinking and reduce populations to passive recipients of potentially harmful technologies. The potential for mRNA to affect interconnected ecosystems is profound. Hypothetical scenarios—such as its introduction into food systems through genetically modified livestock or agriculture—highlight the risks of unintended genetic changes in humans and other organisms. This level of ecological disruption demands far greater scrutiny than it has received. If mRNA technology causes widespread harm, who will be held accountable? Current liability frameworks, which often grant indemnities to pharmaceutical companies, leave the public bearing the risks while corporations reap the rewards. This lack of accountability sets a dangerous precedent for future technological innovations.

The focus on mRNA comes at the expense of proven health interventions, such as improved nutrition, sanitation, and established natural health care platforms. By prioritising experimental technologies, we neglect these foundational public health measures, which definitely have a far greater and more immediate impact on population health.

The economic fallout of potential mRNA-related failures cannot be ignored. Taxpayers will bear the costs of healthcare burdens, eroded public trust, and missed opportunities to invest in safer, more reliable technologies. The damage to Australia’s economy and reputation could be immense. What would responsible innovation look like? It would prioritise comprehensive risk assessment, transparency, and ethical oversight. It would balance ambition with caution, ensuring that new technologies serve humanity without causing harm. By adopting these principles, we can avoid repeating the mistakes of the past and build a safer, more sustainable future.

The construction of mRNA factories in Australia, including the Sydney and Monash University facilities, is, in my view, a monument to madness—a symbol of a society that has lost its way. By embracing a technology with the potential to pollute life itself, we risk not only our own future but the future of the planet. It is imperative that this madness be stopped, and that we reclaim our sovereignty, our environment, and our humanity from the forces of greed and recklessness.

Ian Brighthope